Mrv1572004221607022D 22 24 0 0 0 0 999 V2000型-3.8837 2.2374 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.0587 2.2374 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.3523 1.1104 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.3523 1.9354 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.6378 0.6979 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.6378 2.3479 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.4087 0.8085 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.4087 2.2374 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.5837 0.8085 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.5837 2.2374 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.1387 0.8555 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.8212 1.5229 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.9233 1.1104 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.1712 1.5229 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.6462 1.5229 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.9233 1.9354 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.1387 2.1904 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.0587 0.8085 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.6538 1.5229 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.8838 2.9750 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -2.6462 0.0940 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -3.8837 0.8085 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2 1 1 0 0 0 0 5 4 3 2 0 0 0 0 3 1 0 6 0 0 0 4 1 0 0 0 0 9 7 1 0 0 0 0 10 8 2 0 0 0 0 12 7 2 0 0 0 0 12 8 1 0 0 0 0 13 5 2 0 0 0 0 13 9 11 1 0 0 0 0 14 2 0 0 0 0 14 10 1 0 0 0 0 15 2 1 0 0 0 0 15 12 1 0 0 0 0 16 6 2 0 0 0 0 16 13 1 0 0 0 0 17 18 15 1 0 0 0 0 1 0 0 0 0 19 11 1 0 0 0 0 19 14 1 0 0 0 0 19日17日1 0 0 0 0 20 17 2 0 0 0 0 21 18 2 0 0 0 0 22 18 1 0 0 0 0 M >结束
DB12545 >
drugbank >
CCC (C (O) = O) C1 = CC = C (C = C1) N1CC2 = O CC = CC = C2C1 = >
InChI = 1 s / C18H17NO3 c1-2-15 (18 (21) 22) 12-7-9-14 (10-8-12) 12-7-9-14 (13) 17 (19) 20 / h3-10 15 H, 2、11 h2、h3, (22) H, 21日>
AYDXAULLCROVIT-UHFFFAOYSA-N >
C18H17NO3 >
295.338 >
295.120843411 >
3 >
39 >
32.14378253313398 >
1 >
1 >
0 >
1 >
2 - [4 - (1-oxo-2 3-dihydro-1H-isoindol-2-yl)苯基]丁酸>
3.04 >
3.3057272243333333 >
-3.58 >
0 >
3 >
1 >
13.362774150932516 >
3.825139950625211 >
-3.473020297954665 >
57.61 >
83.7451 >
4 >
1 >
7.81 e-02 g / l >
ibustrin >
0 >
DB12545 >
临床实验的>
Indobufen >
Indobufen $ $ $ $